We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-7.89%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
-$29.7M
Cap. Flow
+$110M
Cap. Flow %
10.28%
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$35.5M
2
GRAB icon
Grab
GRAB
+$33.3M
3
QCOM icon
Qualcomm
QCOM
+$25.7M
4
AMD icon
Advanced Micro Devices
AMD
+$21.8M
5
SE icon
Sea Limited
SE
+$18.2M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$26.6M
2
META icon
Meta Platforms (Facebook)
META
+$16M
3
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$6.5M
4
NBP
NovaBridge Biosciences American Depositary Shares
NBP
+$2.35M
5
UGL icon
ProShares Ultra Gold
UGL
+$1.01M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.29%
2 Technology 26.19%
3 Communication Services 11.91%
4 Healthcare 11.24%
5 Real Estate 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDXX icon
151
Idexx Laboratories
IDXX
$44.5B
$444K 0.04%
1,364
+105
+8% +$38.6K
PRTA icon
152
Prothena Corp
PRTA
$454M
$444K 0.04%
7,329
-2,016
-22% -$63.7K
SAGE
153
DELISTED
Sage Therapeutics
SAGE
$444K 0.04%
11,341
+446
+4% +$17.2K
ALKS icon
154
Alkermes
ALKS
$8.62B
$443K 0.04%
19,839
+3,893
+24% +$101K
KO icon
155
Coca-Cola
KO
$353B
$442K 0.04%
7,882
+135
+2% +$8.39K
RYTM icon
156
Rhythm Pharmaceuticals
RYTM
$7.17B
$442K 0.04%
+18,035
New +$335K
EXC icon
157
Exelon
EXC
$47B
$441K 0.04%
11,772
+465
+4% +$20.6K
BMY icon
158
Bristol-Myers Squibb
BMY
$123B
$439K 0.04%
6,182
+637
+11% +$46.2K
DNLI icon
159
Denali Therapeutics
DNLI
$3.63B
$437K 0.04%
14,254
+2,613
+22% +$85K
CTIC
160
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$437K 0.04%
75,133
+24,962
+50% +$156K
BMRN icon
161
BioMarin Pharmaceuticals
BMRN
$11.4B
$435K 0.04%
5,126
-706
-12% -$62.9K
FOLD
162
DELISTED
Amicus Therapeutics
FOLD
$435K 0.04%
41,712
-10,727
-20% -$120K
KRTX
163
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$431K 0.04%
1,914
-2,402
-56% -$486K
ALNY icon
164
Alnylam Pharmaceuticals
ALNY
$36.4B
$427K 0.04%
2,134
-1,181
-36% -$225K
DVAX
165
DELISTED
Dynavax Technologies
DVAX
$427K 0.04%
40,888
+10,569
+35% +$138K
BAC icon
166
Bank of America
BAC
$424B
$424K 0.04%
14,027
-51
-0.4% -$1.71K
CYTK icon
167
Cytokinetics
CYTK
$10.7B
$423K 0.04%
8,738
-2,348
-21% -$113K
BLUE
168
DELISTED
bluebird bio
BLUE
$422K 0.04%
+3,336
New +$377K
VERV
169
DELISTED
Verve Therapeutics
VERV
$422K 0.04%
+12,292
New +$392K
XEL icon
170
Xcel Energy
XEL
$49.1B
$419K 0.04%
6,541
+258
+4% +$18.8K
MELI icon
171
Mercado Libre
MELI
$92.9B
$418K 0.04%
505
-30,976
-98% -$26.6M
EXEL icon
172
Exelixis
EXEL
$14B
$417K 0.04%
26,611
+2,473
+10% +$47.8K
NTLA icon
173
Intellia Therapeutics
NTLA
$1.53B
$414K 0.04%
7,393
-2,922
-28% -$181K
BPMC
174
DELISTED
Blueprint Medicines
BPMC
$413K 0.04%
6,262
-2,847
-31% -$183K
INSM icon
175
Insmed
INSM
$23.2B
$413K 0.04%
19,185
-1,821
-9% -$43.7K
5 6
7
8 9

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q3 2022 Portfolio in Review

As of Q3 2022, E Fund Management held 349 positions worth $1.07B, down 2.7% from $1.1B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E Fund Management deployed $110M of net new capital in Q3 2022, opening 26 new positions and adding to 163 existing holdings. Its largest new stake was TSMC: 430,000 shares worth $29.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Mercado Libre, an estimated $26.6M trimmed.

  • E Fund Management's largest Q3 2022 buy was TSMC: 430,000 shares worth $29.5M.
  • E Fund Management added most to Grab in Q3 2022, an estimated $33.3M increase.
  • E Fund Management's biggest Q3 2022 reduction was Mercado Libre, cutting an estimated $26.6M.
  • E Fund Management fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q3 2022, selling an estimated $6.5M.
  • E Fund Management's ten largest holdings make up 56% of its $1.07B portfolio in Q3 2022.
  • E Fund Management opened 26 new positions and closed 15 in Q3 2022.
  • E Fund Management's portfolio value fell 2.7% quarter-over-quarter to $1.07B.

Based on E Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.